Citation Impact
Citing Papers
Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis
1990
Anemia in children with chronic kidney disease
2007
Tubular kidney injury molecule‐1 (KIM‐1) in human renal disease
2007 Standout
Identification of the renal erythropoietin-producing cells using transgenic mice
1993 StandoutNobel
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel
2000 Standout
Lack of a role for inducible nitric oxide synthase in an experimental model of nephrotic syndrome
2000
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
2006 Standout
Cross-cultural adaptation of health-related quality of life measures: Literature review and proposed guidelines
1993 Standout
Effect of Gender on the Progression of Nondiabetic Renal Disease
2000
Measurement of SC5b-9 in urine in patients with the nephrotic syndrome
1991
Hematopoietic Growth Factors
1989
Management of idiopathic membranous nephropathy: Evidence-based recommendations
1999
Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants
2006
Role of ‘catalytic’ iron in an animal model of minimal change nephrotic syndrome
1996
The global burden of group A streptococcal diseases
2005 Standout
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
2009 Standout
Genitourinary complications of systemic lupus erythematosus
2000
Fortnightly Review: Glomerulonephritis: diagnosis and treatment
1994
Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis
2016 Standout
Epidemiology of chronic kidney disease: an update 2022
2022 Standout
Titrating Rituximab to Circulating B Cells to Optimize Lymphocytolytic Therapy in Idiopathic Membranous Nephropathy
2007
An introduction to biomarkers: applications to chronic kidney disease
2007
Elevated urinary excretion of the C5b-9 complex in membranous nephropathy
1991
Sites of erythropoietin production
1997 StandoutNobel
Renal and Extrarenal Effects of Gum Arabic (Acacia Senegal) - What Can be Learned from Animal Experiments?
2013 Standout
Transplantation-associated thrombotic microangiopathy after steroid pulse therapy for polyserositis related to graft-versus-host disease
2010 StandoutNobel
Prospective controlled study on mycophenolate mofetil and prednisolone in the treatment of membranous nephropathy with nephrotic syndrome
2007
The interstitial response to renal injury: Fibroblast–like cells show phenotypic changes and have reduced potential for erythropoietin gene expression
1997 StandoutNobel
Proteinuria as a Surrogate Outcome in CKD: Report of a Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration
2009
Hepatitis C infection in two urban hemodialysis units
1990 StandoutNobel
Chronic kidney disease
2011 Standout
Klotho Deficiency Causes Vascular Calcification in Chronic Kidney Disease
2010 Standout
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
2006 Standout
Preoperative erythropoietin in Jehovah's Witnesses who require cardiac procedures
1991
Acute Renal Failure
1996 Standout
Unexpected Role of TRPC6 Channel in Familial Nephrotic Syndrome
2006
RECURRENT GLOMERULONEPHRITIS FOLLOWING RENAL TRANSPLANTATION
1997
Immunohistochemical Analysis of Renin Activity in Chronic Cyclosporine Nephropathy in Childhood Nephrotic Syndrome
2000
Epidemiology of primary glomerular diseases in a French region. Variations according to period and age
1994
Pathophysiology of proteinuria
2003
Production of Erythropoietin by Liver Cells in Vivo and in Vitro
1994 StandoutNobel
Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer
1991 Standout
Development of a chitosan-based wound dressing with improved hemostatic and antimicrobial properties
2008 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Corticosteroids in IgA nephropathy: a randomised controlled trial
1999
Molecular biology of erythropoietin
1993 StandoutNobel
Axonal Transection in the Lesions of Multiple Sclerosis
1998 Standout
Oxidative stress in chronic kidney disease
2018 Standout
The Nephrotic Syndrome
1998
Urinary Excretion of β2-Microglobulin and IgG Predict Prognosis in Idiopathic Membranous Nephropathy
2004
Arterial Hypertension Induced by Erythropoietin and Erythropoiesis-Stimulating Agents (ESA)
2009
Isolated Presence of Antibody to Hepatitis B Core Antigen in Dialysis Patients: Occurrence of Subclinical Hepatitis?
1989
Recombinant Human Erythropoietin in Anemic Patients with End-Stage Renal Disease
1989
Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences
2003 Standout
Early Change in Proteinuria as a Surrogate End Point for Kidney Disease Progression: An Individual Patient Meta-analysis
2014
Rituximab treatment of idiopathic membranous nephropathy
2007
Non-classical processes in surface hemostasis: mechanisms for the poly- N -acetyl glucosamine-induced alteration of red blood cell morphology and surface prothrombogenicity
2008
Erythropoietin in Cardiac Surgery
1993
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
2013 Standout
Transient Receptor Potential Cation Channels in Disease
2007 Standout
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
2017 Standout
The impact of gender on the progression of chronic renal disease
1995
Organ distribution of erythropoietin messenger RNA in normal and uremic rats
1991 StandoutNobel
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
2004 Standout
Chronic Kidney Disease
2016 Standout
Early treatment with corticosteroids ameliorates proteinuria, proliferative lesions, and mesangial phenotypic modulation in adult diffuse proliferative IgA nephropathy
2000 StandoutNobel
Decreased Erythropoietin Response in Patients with the Anemia of Cancer
1990
Anemia of Chronic Disease
2005 Standout
Retinoids Regulate the Repairing Process of the Podocytes in Puromycin Aminonucleoside-induced Nephrotic Rats
2003 StandoutNobel
A modern approach to selectivity of proteinuria and tubulointerstitial damage in nephrotic syndrome
2000
Multiple sclerosis
2002 Standout
Relapse or Worsening of Nephrotic Syndrome in Idiopathic Membranous Nephropathy Can Occur even though the Glomerular Immune Deposits Have Been Eradicated
2011
The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietin
1989
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Immunosuppressive treatment for focal segmental glomerulosclerosis in adults
2008
Limitations of creatinine as a filtration marker in glomerulopathic patients
1985
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
Cell Biology of the Glomerular Podocyte
2003 Standout
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects.
1987
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
Expression of a homologously recombined erythopoietin-SV40 T antigen fusion gene in mouse liver: evidence for erythropoietin production by Ito cells
1994 StandoutNobel
Erythropoietin: Biology and Clinical Use
1989
Tubulointerstitial Changes as a Major Determinant in the Progression of Renal Damage
1992 Standout
Erythropoietin
1991 Standout
Glucocorticoids and control of glomerular filtration rate.
1990
Serum Creatinine as an Index of Renal Function: New Insights into Old Concepts
1992 Standout
Focal segmental glomerulosclerosis in adults
2003
Nephrotic focal segmental glomerulosclerosis in 2004: an update
2004
Molecular mechanisms of glomerular injury in rat experimental membranous nephropathy (Heymann nephritis)
1996
Hypercholesterolaemia and vascular disease after transplantation
1991 StandoutNobel
Hydronephrosis associated with antiurothelial and antinuclear autoantibodies in BALB/c-Fcgr2b −/− Pdcd1 −/− mice
2005 StandoutNobel
2020 International Society of Hypertension Global Hypertension Practice Guidelines
2020 Standout
Clinical pharmacology and economics of recombinant human erythropoietin in end-stage renal disease
1992
National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification
2003 Standout
CytochromeP-450 as a source of catalytic iron in minimal change nephrotic syndrome in rats
2001
Management of idiopathic membranous nephropathy
2010
Treatment of focal segmental glomerulosclerosis
2005
Works of P Passerini being referenced
Validation of a predictive model of idiopathic membranous nephropathy: Its clinical and research implications
1997
Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis?
1999
Treatment of the nephrotic syndrome associated with primary glomerulonephritis
1994
Alkylating Agents and Purine Analogues in Primary Glomerulonephritis with Nephrotic Syndrome
1991
A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy
1995
Other immunosuppressive agents for focal segmental glomerulosclerosis
2003
Remissions and relapses in idiopathic membranous nephropathy.
1992
Controlled Trial of Methylprednisolone and Chlorambucil in Idiopathic Membranous Nephropathy
1984
Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialysis.
1987
Idiopathic membranous nephropathy in the elderly
1993